News
News
- Reputation Launches Competitive Intelligence to Drive Better Business Outcomes
03/29/2022 / 14:00 - GlobeNewswire - Bergen New Bridge Medical Center Earns Top Score in Human Rights Campaign Foundation’s 2022 Healthcare Equality Index
03/28/2022 / 17:00 - GlobeNewswire - RAPT Therapeutics Announces Biomarker Data from Phase 1b Trial of RPT193 Consistent with Disease Modification in Atopic Dermatitis
03/28/2022 / 14:00 - GlobeNewswire - Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treatment for Bladder Cancer at the American Association for Cancer Research Annual Meeting 2022
03/28/2022 / 14:00 - GlobeNewswire - ASLAN Pharmaceuticals Announces Late-Breaker Presentation of Data From Eblasakimab Proof-of-Concept Study at the 2022 American Academy of Dermatology Annual Meeting
03/28/2022 / 13:00 - GlobeNewswire - Dermavant Showcases New Long-Term Durability and Tolerability Data from Phase 3 PSOARING 3 Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 AAD Annual Meeting
03/25/2022 / 13:01 - GlobeNewswire - Applied Epic Recognized as a Leader among Digital Insurance Agency Platforms by Independent Research Firm
03/23/2022 / 17:48 - GlobeNewswire - Jeune Aesthetics Announces Positive Clinical Phase 1 (PEARL-1 Study) Efficacy Results for KB301, an Investigational Gene-based Treatment Designed to Address the Underlying Biology of Aging Skin
03/22/2022 / 12:00 - GlobeNewswire - KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
03/21/2022 / 12:30 - GlobeNewswire - Tonix Pharmaceuticals Announces Phase 3 RALLY Study Results for TNX-102 SL 5.6 mg for the Management of Fibromyalgia
03/21/2022 / 12:00 - GlobeNewswire
Real-time